syncRefreshing market data…
InvestoNGX Intelligence

ETI

Investo's verdict, shared with you

watchmedium confidence3-month horizon
Trades at66.6-10.00%close, 2026-09-15

No fair value published

The derivation ran and was refused by our own plausibility checks. We publish no number rather than a plausible-looking one.

Why · 2 checks

  • Our valuation methods disagree

    The earnings-based and book-based readings of this company differ by more than 2.5×. That spread is real information, but averaging it would manufacture a number no method actually produced.

  • A per-share input was repaired or refused

    One of the per-share figures behind this valuation did not agree with the audited totals it should reconcile to, so it was recomputed from those totals or rejected outright.

What we would need

  • Earnings and book value drawn from the same set of accounts, so the two legs can be reconciled.
  • A per-share figure in the source data that reconciles to the reported totals.
Show what the engine computed

Method spread · 3.34× between the highest and lowest valuation leg.

Methods disagree · The valuation legs disagree by 3.34x (Blended P/E band ₦52.65 vs Blended P/B band ₦154.5 vs Justified P/B ₦46.19). No point estimate is defensible until the inputs are reconciled.

Figure corrected · independently sourced EPS ₦25.52 is 2.45x our filing-derived ₦10.43 — one of the two earnings bases is wrong; the P/E leg is unreliable until resolved

Input quality · independently sourced EPS ₦25.52 is 2.45x our filing-derived ₦10.43 — one of the two earnings bases is wrong; the P/E leg is unreliable until resolved

ETI trades at ₦74 against a P/B-anchored base fair value of ₦97.77 (32% upside) and a current market P/B of 0.64x versus a peer median of 1.34x, suggesting material book-value undervaluation for a pan-African franchise spanning 35 countries. However, a 9.0% filing-derived ROE sits well below ETI's estimated cost of equity (~18%), the justified P/B of only 0.40x implies the stock is already fairly priced on a returns-basis, and a 3.34x disagreement between the three valuation legs — compounded by a 2.45x EPS discrepancy between independent data source and filing-derived data — makes any point estimate unreliable until inputs are reconciled. The honest read is that deep book-value cheapness is real but is substantially offset by sub-cost-of-equity returns, equity base erosion (total equity down 4% H1 2026), and elevated data uncertainty.

Verdict published 2026-09-05 · fundamentals through Q2-2026 · reviewed as the data changes

Source: NGX live market data · Investo intelligence. Educational only — not financial advice.